Efficacy and Safety of Rezafungin and Caspofungin in the Treatment of Patients With Candidaemia and Invasive Candidiasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Infectious Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials
Lancet Infect Dis 2023 Nov 23;[EPub Ahead of Print], GR Thompson, A Soriano, PM Honore, M Bassetti, OA Cornely, M Kollef, BJ Kullberg, J Pullman, M Hites, J Fortún, JP Horcajada, A Kotanidou, AF Das, T Sandison, JA Aram, JA Vazquez, PG PappasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.